Akinda screens Coherus Oncology, Inc. (CHRS) using Islamic finance criteria. The current classification is Not Halal. Screening is informational and not a fatwa; consult a qualified scholar for personal guidance.

Whether a Muslim may invest depends on your school of thought and the stock's Shariah classification. On Akinda, Coherus Oncology, Inc. (CHRS) is currently labeled Not Halal. Always verify with your own research and advisors.

You can view Coherus Oncology, Inc.'s Shariah status on this symbol page (ticker CHRS), in the header, and on the Summary tab. The Akinda app shows the same screening when you search for CHRS.

Coherus Oncology, Inc. (CHRS) receives its label from Akinda's methodology: business activity (non-permissible revenue) and financial ratios (interest-bearing debt and assets) are compared to published thresholds. The result Not Halal reflects those screens at the time of the latest data.

Yes. Coherus Oncology, Inc. (CHRS) can move from Halal to Doubtful or Not halal if revenue mix, debt, or impermissible income crosses Akinda's limits. Check CHRS periodically—Akinda updates results when new filings arrive.